1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Vext Science, Inc.

Vext Science, Inc.

VEXTF
Vext Science, Inc.US flagOther OTC
0.16
USD
+0.00
- -
40.32MMarket Cap

Total Valuation

Vext Science, Inc. carries a market capitalization of 40.32M, placing it among publicly traded companies globally. Its enterprise value stands at 59.19M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap40.32M
Enterprise Value59.19M

Share Statistics

Vext Science, Inc. currently has 247.68M shares outstanding.

Shares Outstanding247.68M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 0.59, and the price-to-book ratio stands at 0.65.

PE RatioN/A
PS Ratio0.59
PB Ratio0.65
P/TBV Ratio-3.52
P/FCF Ratio2.29
P/OCF Ratio3.00

Enterprise Valuation

On an enterprise value basis, Vext Science, Inc. trades at an EV/EBITDA multiple of 5.23 and an EV/FCF ratio of 3.09.

EV / Sales1.14
EV / EBITDA5.23
EV / EBITN/A
EV / FCF3.09

Financial Position

Vext Science, Inc. maintains a current ratio of 0.62, meaning it holds 0.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 62.34, indicating elevated leverage, while an interest coverage ratio of 2.49 demonstrates limited ability to service its debt obligations.

Current Ratio0.62
Quick Ratio0.27
Debt / Equity62.34
Debt / EBITDA3.00
Interest Coverage2.49

Financial Efficiency

Return on Equity (ROE)-27.52
Return on Assets (ROA)-12.54
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)29.83
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover3.61

Taxes

Over the trailing twelve months, Vext Science, Inc. has paid 3.25M in income taxes, reflecting an effective tax rate of 659.85.

Income Tax3.25M
Effective Tax Rate659.85

Stock Price Statistics

Vext Science, Inc.'s stock has gained approximately 40.46592% over the past 52 weeks. The 50-day moving average sits at 0.20, while the 200-day moving average is 0.20.

Beta (5Y)N/A
52-Week Price Change40.46592%
50-Day Moving Average0.20
200-Day Moving Average0.20
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Vext Science, Inc. generated 51.97M in revenue and converted that into -15.55M in net income, yielding earnings per share of -0.09. EBITDA reached 11.31M, while operating income came in at -4.80M.

Revenue51.97M
Gross Profit17.70M
Operating Income-4.80M
Pretax Income-12.30M
Net Income-15.55M
EBITDA11.31M
EBIT-4.80M
Earnings Per Share (EPS)-0.09

Balance Sheet

Vext Science, Inc. holds 5.54M in cash and equivalents against 33.97M in total debt, resulting in a net debt position of 24.60M. Total book value stands at 47.52M, with working capital of -10.32M providing operational flexibility.

Cash & Cash Equivalents5.54M
Total Debt33.97M
Net Debt24.60M
Equity (Book Value)47.52M
Book Value Per Share0.27
Working Capital-10.32M

Cash Flow

Vext Science, Inc. produced 10.25M in operating cash flow over the past twelve months. After subtracting -3.17M in capital expenditures, free cash flow totaled 7.07M - equivalent to 0.04 per share.

Operating Cash Flow10.25M
Capital Expenditures-3.17M
Free Cash Flow7.07M
FCF Per Share0.04

Margins

Vext Science, Inc. operates with a gross margin of 34.06, reflecting its pricing power and cost economics. The operating margin of -9.24 and net profit margin of -29.93 provide insight into operational efficiency.

Gross Margin34.06
Operating Margin-9.24
Pretax Margin-23.68
Profit Margin-29.93
EBITDA Margin21.77

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield13.47
FCF Yield43.61

Scores

Vext Science, Inc. posts an Altman Z-Score of 0.58, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score0.58